Cold-EEZE
Cold-EEZE is a 30-year-old US consumer health brand that manufactures and markets homeopathic zinc-gluconate cold-shortening lozenges across three product lines, selling through national pharmacy and mass-retail chains, Amazon, and a Shopify DTC site to adult consumers seeking shorter cold duration.
- Company typePrivate
- Founded1996
- HeadquartersWindsor, United States
- Headcount—
- GTM typeB2C
- OfferingHardware or Manufacturing
What Cold-EEZE does
Cold-EEZE is a US-based consumer health brand that manufactures and markets homeopathic cold-shortening lozenges containing zinc gluconate as the active ingredient. The company sells a focused portfolio of six SKUs across three product lines — Cold Shortening Lozenges (Natural Cherry, Honey Lemon soft-center, and Sugar-Free Wild Cherry), Plus Defense Lozenges (Manuka Honey & Lemon, Citrus with Elderberry), and Plus Cold & Flu Symptom Relief Lozenges (Mixed Berry). Its core efficacy claim — a 42% reduction in common cold duration when taken at first symptoms — is anchored in a Cleveland Clinic double-blind, placebo-controlled study published in the Annals of Internal Medicine. The proprietary zinc ion release technology is the technical backbone of the formulation, and a soft-center honey lozenge variant differentiates it on sensory experience in the lozenge category.
The company operates a dual go-to-market combining direct-to-consumer e-commerce on its Shopify-based coldeeze.com site with broad retail distribution across CVS, Walgreens, Rite-Aid, Walmart, Target, Kroger, and Amazon in the United States, plus an Amazon Canada storefront. Products are priced at $12.49–$12.99 per unit, with a Subscribe & Save subscription program offering a 15% discount on 1-, 2-, or 3-month cadences. Customer acquisition is supported by multi-channel digital marketing across Facebook, Instagram, TikTok, Pinterest, and YouTube, plus a content engine (MediFacts videos and health blog) and a healthcare-professional sampling program via DoctorSamples.com.
Cold-EEZE is a brand owned by Vespyr Brands, Inc., a privately held New Jersey corporation founded in 1996 with no disclosed funding history, no public listing, and no executive team information in the source material. Manufacturing is performed in FDA-registered facilities, and refunds are processed through WynnPharm Inc. in Freehold, NJ, indicating an outsourced manufacturing or distribution partner relationship. The company serves general consumers, health-conscious buyers seeking sugar-free options, and preventive-health consumers seeking immune support — a horizontally segmented audience rather than concentrated enterprise accounts.
Cold-EEZE firmographics
Firmographics- Name
- Cold-EEZE
- Legal name
- Vespyr Brands, Inc.
- Website
- https://coldeeze.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Short description
- Cold-EEZE is a 30-year-old US consumer health brand that manufactures and markets homeopathic zinc-gluconate cold-shortening lozenges across three product lines, selling through national pharmacy and mass-retail chains, Amazon, and a Shopify DTC site to adult consumers seeking shorter cold duration.
- Ownership category
- akta.pro rank
Cold-EEZE industry classification
Industry- Product category
- OTC Cold & Flu Remedies
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)
- akta.pro secondary industry
- Cold, Flu & Cough Remedies (HLAIADAB)
Keywords
Where Cold-EEZE is headquartered
LocationHeadquarters
- HQ city
- Windsor
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Cold-EEZE business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Marketing or Sales, Operations, Personnel, Others
Revenue model
- Product Sales: Cold-EEZE generates revenue through direct-to-consumer e-commerce sales on coldeeze.com and through retail distribution partnerships with major pharmacy and grocery chains. Products are sold as one-time purchases or through a Subscribe & Save program offering 15% discount for recurring subscriptions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard one-time purchase pricing for Cold Shortening Lozenges |
| Subscription | Monthly | Subscribe & Save subscription pricing |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels5 records
Cold-EEZE product offering
Product offeringCore offering
Cold-EEZE manufactures and sells homeopathic cold-shortening lozenges formulated with zinc gluconate as the active ingredient. The portfolio includes core Cold Shortening Lozenges in Natural Cherry, Natural Liquid Honey Lemon (soft-center), and Sugar-Free Wild Cherry variants, plus tiered extensions such as Plus Defense Lozenges and Plus Cold & Flu Symptom Relief Lozenges that layer immune-supporting homeopathic actives. All products are clinically positioned to shorten common cold duration and are sold directly to consumers and through major retail pharmacies.
Product overview
Cold-EEZE is a homeopathic cold remedy brand marketed under Vespyr Brands, LLC. The product line consists of two tiers: (1) Core Cold Shortening Lozenges — available in Natural Cherry, Natural Liquid Honey Lemon (soft-center format), and Sugar-Free Wild Cherry variants — all containing zinc gluconate as the active ingredient, clinically proven to reduce common cold duration by 42% per Cleveland Clinic study; (2) Plus-tier products (Plus Defense and Plus Cold & Flu Symptom Relief) that layer homeopathic active ingredients (Echinacea, Rose Hips, Elderberry, Licorice Root, Oats) onto the zinc gluconate base to provide additional immune support and symptom relief. All products are available exclusively as lozenges.
Differentiator
Problem solved
Functional benefit
Brands
- Cold-EEZE Plus Defense: Product line that shortens cold duration and promotes immune health with additional ingredients like Echinacea and Rose Hips.
- Cold-EEZE Plus Cold & Flu
Products and services
- Cold Shortening Lozenges (Natural Cherry)
Quantifiable outcome
- 42% reduction in cold duration when taken at first sign of cold and used as directed
- +2 more outcomes
Companies that use Cold-EEZE
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles4 records
Cold-EEZE technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Cold-EEZE partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered minor and core.
- DoctorSamples.comminorCold-EEZE partners with DoctorSamples.com to facilitate their free patient sample program, allowing healthcare providers to request sample kits of Cold-EEZE products for distribution to patients.
- Cleveland CliniccoreCleveland Clinic conducted the pivotal double-blind placebo-controlled clinical study that validated Cold-EEZE's 42% reduction in cold duration claim. Study published in peer-reviewed Annals of Internal Medicine.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Cold-EEZE competitors and assessment
Company assessmentDirect peers
- Zicam: Zicam is the closest direct peer — also a zinc-based cold-shortening lozenge brand marketed for reducing cold duration, directly competing with Cold-EEZE on mechanism, format, and shelf placement in the same OTC 'cold shortening' subcategory.
- Airborne: Airborne sells immune-support gummies, lozenges, and tablets positioned similarly to Cold-EEZE's Plus Defense line, targeting the same preventive-health consumer segment with homeopathic-leaning claims.
- Ricola: Ricola is a Swiss herbal lozenge brand selling cough and sore throat drops in the same retailers as Cold-EEZE, with comparable pricing and a natural-ingredient value proposition.
- Zarbee's: Zarbee's markets natural cough, cold, and immune syrups and lozenges targeted at adults and children, sharing Cold-EEZE's positioning around homeopathic and naturally-derived OTC remedies.
- Fisherman's Friend: Fisherman's Friend is a heritage strong-menthol lozenge brand with comparable global distribution depth and a long-tenured consumer base for cold and sore throat relief.
- Hyland's: Hyland's is a homeopathic OTC brand selling cold, cough, and immune products for adults and children, directly mirroring Cold-EEZE's homeopathic positioning and regulatory exposure.
- Sambucol: Sambucol markets elderberry-based immune support products (lozenges, syrups, gummies) that overlap with Cold-EEZE's Plus Defense elderberry variants, competing for the same immune-support consumer.
Broad incumbents
- Halls: Halls (Mondelez) is the dominant mass-market cough drop brand, sharing Cold-EEZE's lozenge format and retail placement, but positioned around symptom relief (menthol) rather than cold duration reduction.
- Mucinex (Reckitt Benckiser): Mucinex is a broad cold/flu OTC medication brand owned by Reckitt, providing category-wide competition for cold symptom relief and immune support across multiple formats.
- Vicks (Procter & Gamble): Vicks is the largest cold/flu brand (P&G) with VapoRub, NyQuil, DayQuil, and cough drops, serving the same cold-and-flu consumer from a much wider portfolio and broader international distribution than Cold-EEZE.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Cold-EEZE social profiles
Digital presenceCold-EEZE financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cold-EEZE leadership team
Management profileNumber of profiles
Profiles1 record
Cold-EEZE funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cold-EEZE M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cold-EEZE
What does Cold-EEZE do?
Cold-EEZE manufactures and sells homeopathic cold-shortening lozenges formulated with zinc gluconate as the active ingredient. The portfolio includes core Cold Shortening Lozenges in Natural Cherry, Natural Liquid Honey Lemon (soft-center), and Sugar-Free Wild Cherry variants, plus tiered extensions such as Plus Defense Lozenges and Plus Cold & Flu Symptom Relief Lozenges that layer immune-supporting homeopathic actives. All products are clinically positioned to shorten common cold duration and are sold directly to consumers and through major retail pharmacies.
Is Cold-EEZE a public or private company?
Cold-EEZE is a private company. It is classified as corporate owned and is currently operating.
When was Cold-EEZE founded?
Cold-EEZE was founded in 1996.
Where is Cold-EEZE based?
Cold-EEZE is headquartered in Windsor, United States, in the North America region.
How does Cold-EEZE make money?
One revenue line is on record: product Sales.
Who are Cold-EEZE's main competitors?
Direct peers on record are Zicam, Airborne, Ricola, Zarbee's, Fisherman's Friend, Hyland's and Sambucol. Broad incumbents are Halls, Mucinex (Reckitt Benckiser) and Vicks (Procter & Gamble).
Does Cold-EEZE have an API?
No public API is recorded for Cold-EEZE.
What industry is Cold-EEZE in?
Cold-EEZE's product category is OTC Cold & Flu Remedies. Its primary akta.pro industry code is CRADAMAD, Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges), with a secondary code of HLAIADAB, Cold, Flu & Cough Remedies. Its SIC code is 5122.